A. Gerards

2.6k total citations · 1 hit paper
29 papers, 2.0k citations indexed

About

A. Gerards is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, A. Gerards has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 11 papers in Hematology and 7 papers in Immunology. Recurrent topics in A. Gerards's work include Rheumatoid Arthritis Research and Therapies (23 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune and Inflammatory Disorders Research (11 papers). A. Gerards is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (23 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune and Inflammatory Disorders Research (11 papers). A. Gerards collaborates with scholars based in Netherlands, Gabon and Israel. A. Gerards's co-authors include D. van Zeben, Ben A. C. Dijkmans, P. J. S. M. Kerstens, Y P M Goekoop-Ruiterman, Cornelia F Allaart, M V van Krugten, Jeska K de Vries‐Bouwstra, J.H.L.M. van Groenendael, M L Westedt and Willem F. Lems and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Clinical Rheumatology.

In The Last Decade

A. Gerards

28 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

2005 1.1k citations Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Gerards Netherlands	14	1.7k	749	383	336	268	29	2.0k
J.H.L.M. van Groenendael Netherlands	16	1.9k 1.1×	744 1.0×	406 1.1×	324 1.0×	282 1.1×	22	2.1k
K. H. Han Netherlands	10	1.6k 0.9×	633 0.8×	355 0.9×	243 0.7×	252 0.9×	16	1.8k
Y P M Goekoop-Ruiterman Netherlands	20	2.4k 1.4×	880 1.2×	485 1.3×	399 1.2×	348 1.3×	30	2.6k
Koichi Amano Japan	28	1.4k 0.8×	431 0.6×	524 1.4×	477 1.4×	370 1.4×	133	2.2k
J Jäger Australia	3	1.2k 0.7×	577 0.8×	255 0.7×	294 0.9×	173 0.6×	5	1.4k
M. Lange United States	6	1.7k 1.0×	941 1.3×	277 0.7×	574 1.7×	234 0.9×	7	2.2k
Joy Schechtman United States	11	1.1k 0.6×	421 0.6×	360 0.9×	533 1.6×	259 1.0×	17	1.7k
Leroy R. Lard Netherlands	16	998 0.6×	536 0.7×	425 1.1×	208 0.6×	175 0.7×	25	1.5k
Jacques‐Eric Gottenberg France	20	961 0.6×	324 0.4×	248 0.6×	328 1.0×	185 0.7×	58	1.5k
P. L. C. M. van Riel Netherlands	19	931 0.6×	332 0.4×	202 0.5×	285 0.8×	295 1.1×	25	1.3k

Countries citing papers authored by A. Gerards

Since Specialization

Citations

This map shows the geographic impact of A. Gerards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gerards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gerards more than expected).

Fields of papers citing papers by A. Gerards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gerards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gerards. The network helps show where A. Gerards may publish in the future.

Co-authorship network of co-authors of A. Gerards

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gerards. A scholar is included among the top collaborators of A. Gerards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gerards. A. Gerards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vis, Marijn, Laura C. Coates, Anushka Soni, et al.. (2022). Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Research & Therapy. 24(1). 22–22. 40 indexed citations

Vis, Marijn, Laura C. Coates, Anil Kumar Soni, et al.. (2020). OP0057 SEX SPECIFIC DIFFERENCES IN EARLY PSORIATIC ARTHRITIS. Annals of the Rheumatic Diseases. 79. 38–39. 2 indexed citations

Luime, J., Marijn Vis, Marc R. Kok, et al.. (2020). Lessons learned from clinical phenotypes in early psoriatic arthritis: the real-world Dutch south west Early Psoriatic ARthritis study. Scandinavian Journal of Rheumatology. 50(2). 124–131. 21 indexed citations

Ven, Myrthe van der, et al.. (2017). Absence of ultrasound inflammation in patients presenting with arthralgia rules out the development of arthritis. Arthritis Research & Therapy. 19(1). 202–202. 35 indexed citations

Kuijper, T. Martijn, Jolanda J. Luime, Pascal H P de Jong, et al.. (2016). Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial. Annals of the Rheumatic Diseases. 75(12). 2119–2123. 28 indexed citations

Heslinga, S.C., Michael T. Nurmohamed, A. Gerards, et al.. (2016). SAT0416 Significantly Reduced Recurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis during Treatment with Golimumab. Annals of the Rheumatic Diseases. 75. 820–821.

Ven, Myrthe van der, T. Martijn Kuijper, A. Gerards, et al.. (2015). THU0108 No Clear Association Between the Presence of Subclinical Synovitis and Patient Reported Outcomes in RA Patients in Remission. Annals of the Rheumatic Diseases. 74. 232–233. 1 indexed citations

Hazes, J. M. W., Martijn Huisman, D. van Zeben, et al.. (2014). Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial. Annals of the Rheumatic Diseases. 73(7). 1331–1339. 92 indexed citations

Gerards, A., et al.. (2013). Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients. Scandinavian Journal of Rheumatology. 43(1). 9–16. 12 indexed citations

10.

Weel, A., A.M. Huisman, A. Gerards, et al.. (2012). Brief Report: To squeeze or not to squeeze, that is the question! Optimizing the Disease Activity Score in 28 joints by adding the squeeze test of metatarsophalangeal joints in early rheumatoid arthritis. Arthritis & Rheumatism. 64(10). 3095–3101. 6 indexed citations

11.

Jong, Pascal H P de, R. A. M. Quax, Margriet Huisman, et al.. (2012). Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study. Annals of the Rheumatic Diseases. 72(10). 1659–1663. 14 indexed citations

12.

Hazes, Johanna M. W., P J Barendregt, Martijn Huisman, et al.. (2012). Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial. Annals of the Rheumatic Diseases. 72(1). 72–78. 97 indexed citations

13.

Broek, Maries van den, Linda Dirven, Jeska K de Vries‐Bouwstra, et al.. (2012). Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up. Annals of the Rheumatic Diseases. 71(9). 1530–1533. 29 indexed citations

14.

Klarenbeek, Naomi B., Désirée van der Heijde, A. Gerards, et al.. (2011). Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. Annals of the Rheumatic Diseases. 70(10). 1815–1821. 87 indexed citations

15.

Kooij, S M van der, Jeska K de Vries‐Bouwstra, Y P M Goekoop-Ruiterman, et al.. (2007). Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Annals of the Rheumatic Diseases. 66(10). 1356–1362. 71 indexed citations

16.

Goekoop-Ruiterman, Y P M, Jeska K de Vries‐Bouwstra, Cornelia F Allaart, et al.. (2005). Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis & Rheumatism. 52(11). 3381–3390. 1104 indexed citations breakdown →

17.

Gerards, A., et al.. (2004). Two Inhibitors of DNA‐Synthesis Lead to Inhibition of Cytokine Production via a Different Mechanism. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1089–1100. 11 indexed citations

18.

Gerards, A., et al.. (2003). Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial. Annals of the Rheumatic Diseases. 62(4). 291–296. 81 indexed citations

19.

Gerards, A., et al.. (2003). Destructive joint disease in α-mannosidosis. A case report and review of the literature. Clinical Rheumatology. 23(1). 40–42. 8 indexed citations

20.

Gerards, A.. (2003). Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. British journal of rheumatology. 42(10). 1189–1196. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact